Cargando…
The application of patient-derived organoid in the research of lung cancer
Lung cancer is the most common cancer and the leading cause of cancer-related death worldwide. However, mechanisms of its progression remained unclear and new treatments against this disease are rapidly emerging. As a novel preclinical model, patient-derived organoid (PDO) can also be established fr...
Autores principales: | Li, Yin, Gao, Xinyu, Ni, Chao, Zhao, Bing, Cheng, Xinghua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10205850/ https://www.ncbi.nlm.nih.gov/pubmed/36696006 http://dx.doi.org/10.1007/s13402-023-00771-3 |
Ejemplares similares
-
Organoid technology and applications in cancer research
por: Xu, Hanxiao, et al.
Publicado: (2018) -
Progress in the application of organoids to breast cancer research
por: Yang, Liping, et al.
Publicado: (2020) -
Application of Patient-Derived Cancer Organoids to Personalized Medicine
por: Shiihara, Masahiro, et al.
Publicado: (2022) -
Patient-derived organoids of lung cancer based on organoids-on-a-chip: enhancing clinical and translational applications
por: Zeng, Xiao, et al.
Publicado: (2023) -
Advanced lung organoids and lung-on-a-chip for cancer research and drug evaluation: a review
por: Zhu, Leqing, et al.
Publicado: (2023)